BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 540 filers reported holding BIO-TECHNE CORP in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,479,345 | -16.9% | 21,733 | -0.4% | 0.60% | -17.2% |
| Q2 2023 | $1,780,486 | +7.8% | 21,812 | -2.0% | 0.72% | -0.8% |
| Q1 2023 | $1,651,211 | -11.4% | 22,257 | -1.1% | 0.73% | -20.5% |
| Q4 2022 | $1,864,283 | +16.3% | 22,494 | +298.5% | 0.91% | +4.5% |
| Q3 2022 | $1,603,000 | -18.0% | 5,644 | +0.1% | 0.88% | -10.0% |
| Q2 2022 | $1,955,000 | -20.1% | 5,639 | -0.2% | 0.97% | -5.5% |
| Q1 2022 | $2,446,000 | -16.3% | 5,649 | +0.1% | 1.03% | -16.5% |
| Q4 2021 | $2,921,000 | -1.1% | 5,646 | -7.4% | 1.23% | -7.0% |
| Q3 2021 | $2,953,000 | +7.0% | 6,094 | -0.6% | 1.32% | +5.2% |
| Q2 2021 | $2,760,000 | +15.3% | 6,129 | -2.2% | 1.26% | +3.4% |
| Q1 2021 | $2,394,000 | +20.4% | 6,268 | +0.1% | 1.22% | +13.9% |
| Q4 2020 | $1,989,000 | +21.1% | 6,263 | -5.6% | 1.07% | +10.1% |
| Q3 2020 | $1,643,000 | -11.8% | 6,633 | -5.9% | 0.97% | -21.8% |
| Q2 2020 | $1,862,000 | +37.5% | 7,051 | -1.3% | 1.24% | +0.8% |
| Q1 2020 | $1,354,000 | -13.9% | 7,143 | -0.3% | 1.23% | +8.1% |
| Q4 2019 | $1,572,000 | +12.0% | 7,162 | -0.2% | 1.14% | -1.6% |
| Q3 2019 | $1,404,000 | -6.7% | 7,175 | -0.6% | 1.16% | -10.7% |
| Q2 2019 | $1,505,000 | +2.3% | 7,220 | -2.6% | 1.30% | -1.2% |
| Q1 2019 | $1,471,000 | +37.3% | 7,411 | +0.1% | 1.31% | +11.1% |
| Q4 2018 | $1,071,000 | -29.1% | 7,400 | -0.2% | 1.18% | -23.7% |
| Q3 2018 | $1,511,000 | +95.2% | 7,412 | +41.6% | 1.55% | +111.3% |
| Q2 2018 | $774,000 | +1.3% | 5,234 | -0.8% | 0.73% | -4.9% |
| Q1 2018 | $764,000 | +6.4% | 5,274 | +0.2% | 0.77% | +4.0% |
| Q4 2017 | $718,000 | – | 5,265 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 300,000 | $24,489,000 | 21.05% |
| Montanaro Asset Management Ltd | 388,800 | $31,737,744 | 5.02% |
| Sandhill Capital Partners LLC | 502,447 | $41,014,775 | 3.74% |
| Brown Capital Management | 3,160,892 | $258,023,614 | 3.66% |
| DF DENT & CO INC | 3,275,617 | $267,388,640 | 3.62% |
| Ownership Capital B.V. | 2,282,104 | $186,288,150 | 3.26% |
| Jackson Square Partners, LLC | 1,361,789 | $111,162,836 | 3.24% |
| STONE RUN CAPITAL, LLC | 88,135 | $7,194,460 | 3.20% |
| Pembroke Management, LTD | 339,591 | $27,720,813 | 2.99% |
| Summit Creek Advisors LLC | 283,693 | $23,157,860 | 2.90% |